BioPharma Dive August 9, 2025
Less than two weeks after stepping down, Prasad will return to lead the agency office overseeing vaccines and gene therapy “at the FDA’s request,” according to an HHS spokesperson.
Vinay Prasad will return to lead the Food and Drug Administration office that oversees vaccines and gene therapy in a stunning reversal that comes less than two weeks after he abruptly left the job.
Andrew Nixon, a spokesperson for the Department of Health and Human Services, confirmed Prasad’s return in an emailed statement Saturday. “At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center of Biologics Evaluation and Research,” Nixon wrote.
The news was reported earlier by Endpoints News and Stat news.
Prasad’s return marks the...
Today's Sponsors
Today's Sponsor